1. Stocks
  2. Aarti Drugs Ltd.
  3. Swot
swot-logo

Aarti Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Aarti Drugs Ltd. has 14 Strengths, 6 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout Second Resistance ( LTP > R2)

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Mid-range Performer (DVM)

Companies with high TTM EPS Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Decline in Quarterly Net Profit (YoY)

Declining Net Cash Flow : Companies not able to generate net cash

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Red Flag: Companies seeing significant coronavirus impact

Rising Delivery Percentage Compared to Prev Day

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)